Bulk Manufacturer of Controlled Substances Application: Vici Health Sciences, LLC, 69342 [2022-25174]
Download as PDF
<![CDATA[
69342
Federal Register / Vol. 87, No. 222 / Friday, November 18, 2022 / Notices
According to Florida statute, ‘‘A
practitioner, in good faith and in the
course of his or her professional practice
only, may prescribe, administer,
dispense, mix, or otherwise prepare a
controlled substance.’’ Fla. Stat.
893.05(1)(a) (2022). Further, a
‘‘practitioner’’ as defined by Florida
statute includes ‘‘a physician assistant
licensed under chapter 458 or 459.’’ 3 Id.
at 893.02(23).
Here, the undisputed evidence in the
record is that Respondent is not
currently a licensed practitioner in
Florida, and a physician assistant must
be a licensed practitioner to dispense a
controlled substance in Florida. Thus,
because Respondent lacks authority to
handle controlled substances in Florida,
Respondent is not eligible to maintain a
DEA registration based in Florida.
Accordingly, the Agency will order that
Respondent’s DEA registration be
revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. MD4826915 issued
to Adley Dasilva, P.A. Further, pursuant
to 28 CFR 0.100(b) and the authority
vested in me by 21 U.S.C. 823(f), I
hereby deny any pending applications
of Adley Dasilva, P.A., to renew or
modify this registration, as well as any
other pending application of Adley
Dasilva, P.A., for additional registration
in Florida. This Order is effective
December 19, 2022.
Signing Authority
khammond on DSKJM1Z7X2PROD with NOTICES
This document of the Drug
Enforcement Administration was signed
on November 9, 2022, by Administrator
Anne Milgram. That document with the
original signature and date is
maintained by DEA. For administrative
purposes only, and in compliance with
requirements of the Office of the Federal
Register, the undersigned DEA Federal
Register Liaison Officer has been
authorized to sign and submit the
document in electronic format for
publication, as an official document of
DEA. This administrative process in no
way alters the legal effect of this
document upon publication in the
Federal Register.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1096]
Bulk Manufacturer of Controlled
Substances Application: Vici Health
Sciences, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
SUMMARY: Vici Health Sciences, LLC has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 17, 2023. Such
persons may also file a written request
for a hearing on the application on or
before January 17, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 5, 2022, Vici
Health Sciences, LLC, 6655 Amberton
Drive, Suite N, Elkridge, Maryland
21075, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled
substance
Drug code
Jkt 259001
PO 00000
Frm 00105
Notice of Lodging of Proposed
Consent Decree Under the Clean Water
Act
On November 14, 2022, the
Department of Justice lodged a proposed
Consent Decree with the United States
District Court for the Southern District
of Illinois in the lawsuit entitled United
States and the State of Illinois v. Prairie
State Solar, LLC, Civil Action No. 3:22–
cv–02660.
In this case, the United States and the
State seek to resolve claims against
Defendant Prairie State Solar, LLC
under the Clean Water Act. The United
States and the State allege Prairie States
violated its state stormwater permit
during the construction of a large-scale
solar farm in Perry County, Illinois. The
proposed Consent Decree requires
Prairie State to perform injunctive relief
measures to ensure compliance until
construction is complete and the
stormwater permit is terminated. The
Consent Decree also requires Prairie
State to pay a civil penalty of $225,000,
with $157,500 to the United States and
$67,500 to the State of Illinois.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States and The State of Illinois
v. Prairie State Solar, D.J. Ref. No. 90–
5–1–1–12558/1. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
The company plans to bulk
manufacture the listed controlled
18:44 Nov 17, 2022
BILLING CODE P
Schedule
3 Chapter 458 regulates medical practice and
applies to Respondent. GX B, at 2.
VerDate Sep<11>2014
[FR Doc. 2022–25174 Filed 11–17–22; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
[FR Doc. 2022–25103 Filed 11–17–22; 8:45 am]
Kristi O’Malley,
Assistant Administrator.
AGENCY:
Ibogaine ............
Fentanyl relatedcompounds as
defined in 21
CFR
1308.11(h).
Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.
substances or their intermediates for
sale to its customers. No other activities
for these drug codes are authorized for
this registration.
Fmt 4703
7260
9850
Sfmt 4703
I
I
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
E:\FR\FM\18NON1.SGM
18NON1
]]>Agencies
[Federal Register Volume 87, Number 222 (Friday, November 18, 2022)]
[Notices]
[Page 69342]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25174]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1096]
Bulk Manufacturer of Controlled Substances Application: Vici
Health Sciences, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Vici Health Sciences, LLC has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
January 17, 2023. Such persons may also file a written request for a
hearing on the application on or before January 17, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 5, 2022, Vici Health Sciences, LLC, 6655
Amberton Drive, Suite N, Elkridge, Maryland 21075, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Ibogaine........................... 7260 I
Fentanyl related-compounds as 9850 I
defined in 21 CFR 1308.11(h).
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances or their intermediates for sale to its customers. No other
activities for these drug codes are authorized for this registration.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-25174 Filed 11-17-22; 8:45 am]
BILLING CODE P
